EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access

Mobile Health Technology for Personalized Tobacco Cessation Support Among Cancer Survivors and Caregivers in Laos (Project SurvLaos): Protocol for a Pilot Randomized Controlled Trial

Phayvanh Keopaseuth iD, Phonepadith Xangsayarath iD, Shweta Kulkarni iD, Khatthanaphone Phandouangsy iD, Chanthavy Soulaphy iD, Phetsamone Alounlungsy iD, Vangnakhone Dittaphong iD, Dalouny Xayavong iD, Champadeng Vongdala iD, Latsamy Siengsounthone iD, Michael Businelle iD, Summer G Frank-Pearce iD und 3 weitere

JMIR Research Protocols · 2025

DOI: 10.2196/66517 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Phayvanh Keopaseuth und 14 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Health of Lao People's Democratic Republic, Vientiane Capital, Lao People's Democratic Republic. Hauptthemen laut MEDLINE: Cancer Survivors, Caregivers, Smoking Cessation, Tobacco Use Cessation. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tobacco use remains a major cause of preventable deaths and evidence suggests that smoking cessation offers considerable benefits for patients with and survivors of cancer. In the Lao People’s Democratic Republic (Lao PDR), approximately 60% of male patients and 15% of female patients with cancer smoke cigarettes. Nevertheless, there is no tobacco treatment program for this population.

Objective

This pilot randomized controlled trial (RCT) aims to evaluate the feasibility and preliminary efficacy of our mobile health–based automated treatment (AT) program to help Lao cancer survivors and caregivers quit smoking cigarettes.

Methods

We used an intervention mixed methods research design, which included a pilot 2-group interventional RCT and an embedded qualitative component to explain RCT outcomes. In the pilot RCT, cancer survivors or caregivers (n=80, no dyads) who smoked were recruited from national hospitals in Vientiane. Recruited participants were randomized to 1 of 2 treatment groups: standard care (SC) or AT. SC consisted of brief advice to quit smoking delivered by research staff, self-help written materials, and a 2-week supply of nicotine replacement therapy (transdermal patches). AT consisted of all SC components plus our fully automated, interactive, smartphone-based behavioral treatment program personalized and tailored to cancer survivors or caregivers and delivered by our Insight app. Feasibility outcomes of interest include the percentages of intervention messages delivered and viewed, and participant retention at the 3-month follow-up. The preliminary efficacy outcome is biochemically confirmed self-reported 7-day point prevalence abstinence at 3 months post study enrollment. During the interventional RCT and after the 3-month follow-up assessment, we used additional open-ended questions to explore why and how the participants did or did not successfully quit smoking and stay abstinent.

Results

Data collection occurred from April 2022 to May 2023. Outcome analyses are ongoing, and results are expected to be published in 2025.

Conclusions

Our course of research will address the critical need of having a scalable and sustainable tobacco cessation treatment program for patients with cancer and their caregivers in Lao PDR. The preliminary data from this pilot project will lay a foundation for a subsequent fully powered RCT to evaluate the actual efficacy of our mobile health–based AT program. Ultimately, our course of research will contribute to reducing tobacco-related complications in cancer treatments, comorbidities, tobacco-related cancer recurrence, and mortality rates in Lao PDR. Trial Registration ClinicalTrials.gov NCT05253573; https://clinicaltrials.gov/study/NCT05253573 International Registered Report Identifier (IRRID) DERR1-10.2196/66517

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsCaregiversSmoking CessationTobacco Use CessationHumansLaosPilot ProjectsMaleFemaleTelemedicineAdultMiddle AgedMobile ApplicationsRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Lao People’s Democratic Republiccancer survivorshipmHealthsmoking cessationtobacco cessationtobacco dependence

Autor:innen und Institutionen

  • Ministry of Health of Lao People's Democratic Republic, Vientiane Capital, Lao People's Democratic Republic.
  • Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences, Oklahoma City, OK, United States.
  • Secretariat of the National Tobacco Control Committee, Vientiane Capital, Lao People's Democratic Republic.
  • National Center for Laboratory and Epidemiology, Ministry of Health of Lao PDR, Vientiane Capital, Lao People's Democratic Republic.
  • Lao National Cancer Center, Ministry of Health of Lao PDR, Vientiane Capital, Lao People's Democratic Republic.
  • Setthathirath Hospital, Vientiane Capital, Lao People's Democratic Republic.

ORCID-Profile: Phayvanh Keopaseuth, Phonepadith Xangsayarath, Shweta Kulkarni, Khatthanaphone Phandouangsy, Chanthavy Soulaphy, Phetsamone Alounlungsy, Vangnakhone Dittaphong, Dalouny Xayavong, Champadeng Vongdala, Latsamy Siengsounthone, Michael Businelle, Summer G Frank-Pearce, Damon J Vidrine, Jennifer I Vidrine, Thanh Cong Bui

Förderung

  • NCI NIH HHS

Zitieren

APA

Keopaseuth, P., Xangsayarath, P., Kulkarni, S., Phandouangsy, K., Soulaphy, C., Alounlungsy, P., Dittaphong, V., Xayavong, D., Vongdala, C., Siengsounthone, L., Businelle, M., Frank-Pearce, S. G., Vidrine, D. J., Vidrine, J. I., & Bui, T. C. (2025). Mobile Health Technology for Personalized Tobacco Cessation Support Among Cancer Survivors and Caregivers in Laos (Project SurvLaos): Protocol for a Pilot Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/66517

Vancouver

Keopaseuth P, Xangsayarath P, Kulkarni S, Phandouangsy K, Soulaphy C, Alounlungsy P, et al. Mobile Health Technology for Personalized Tobacco Cessation Support Among Cancer Survivors and Caregivers in Laos (Project SurvLaos): Protocol for a Pilot Randomized Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/66517

BibTeX
@article{Keopaseuth2025,
  author = {Keopaseuth, Phayvanh and Xangsayarath, Phonepadith and Kulkarni, Shweta and Phandouangsy, Khatthanaphone and Soulaphy, Chanthavy and Alounlungsy, Phetsamone and Dittaphong, Vangnakhone and Xayavong, Dalouny and Vongdala, Champadeng and Siengsounthone, Latsamy and Businelle, Michael and Frank-Pearce, Summer G and Vidrine, Damon J and Vidrine, Jennifer I and Bui, Thanh Cong},
  title = {Mobile Health Technology for Personalized Tobacco Cessation Support Among Cancer Survivors and Caregivers in Laos (Project SurvLaos): Protocol for a Pilot Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/66517}
}
Kostenlos starten →